Cargando…

Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia

BACKGROUND: Macroprolactin mostly composed of an immunoglobulin G (IgG) and a monomeric prolactin (PRL) represents the major circulating PRL form in the patients with macroprolactinemia that are usually asymptomatic and may not require treatment. In this study, we aimed to evaluate the prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chao, Fan, Fei, Hu, Siqi, Meng, Lingxin, Xu, Dong, Wang, Juan, Chen, Lu, Liu, Jingrui, Dong, Ying, Lu, Yifan, Shen, Min, Zhai, Yanhong, Cao, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676205/
https://www.ncbi.nlm.nih.gov/pubmed/32597541
http://dx.doi.org/10.1002/jcla.23456
_version_ 1783611724179439616
author Yu, Chao
Fan, Fei
Hu, Siqi
Meng, Lingxin
Xu, Dong
Wang, Juan
Chen, Lu
Liu, Jingrui
Dong, Ying
Lu, Yifan
Shen, Min
Zhai, Yanhong
Cao, Zheng
author_facet Yu, Chao
Fan, Fei
Hu, Siqi
Meng, Lingxin
Xu, Dong
Wang, Juan
Chen, Lu
Liu, Jingrui
Dong, Ying
Lu, Yifan
Shen, Min
Zhai, Yanhong
Cao, Zheng
author_sort Yu, Chao
collection PubMed
description BACKGROUND: Macroprolactin mostly composed of an immunoglobulin G (IgG) and a monomeric prolactin (PRL) represents the major circulating PRL form in the patients with macroprolactinemia that are usually asymptomatic and may not require treatment. In this study, we aimed to evaluate the prevalence of antithyroid and antinuclear antibodies, as well as the IgG subclass distributions in the patients suspected for macroprolactinemia. METHODS: From January to July in 2018, totally 317 patients with elevated PRL were subjected to the polyethylene glycol (PEG) precipitation assay. The patients with recovery rates of ≤60% were subjected for IgG subclass determination and autoantibody testing including thyroid peroxidase antibody (aTPO), antithyroglobulin antibody (aTG), and antinuclear antibodies (ANA). RESULTS: The higher the post‐PEG PRL recovery rates, the less typical hyperprolactinemia symptoms and the higher prevalence of autoantibodies were observed. The IgG1 and IgG3 were the predominant subclasses in the PRL‐IgG complexes according to the immunoprecipitation experiments. CONCLUSION: The patients with post‐PEG PRL recovery rates of <40% and 40%‐60% were likely to represent two distinct populations of different clinical presentations. The prevalence of autoantibodies and IgG subclasses distribution suggested their pathogenic significance in the development of macroprolactinemia.
format Online
Article
Text
id pubmed-7676205
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76762052020-11-24 Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia Yu, Chao Fan, Fei Hu, Siqi Meng, Lingxin Xu, Dong Wang, Juan Chen, Lu Liu, Jingrui Dong, Ying Lu, Yifan Shen, Min Zhai, Yanhong Cao, Zheng J Clin Lab Anal Research Articles BACKGROUND: Macroprolactin mostly composed of an immunoglobulin G (IgG) and a monomeric prolactin (PRL) represents the major circulating PRL form in the patients with macroprolactinemia that are usually asymptomatic and may not require treatment. In this study, we aimed to evaluate the prevalence of antithyroid and antinuclear antibodies, as well as the IgG subclass distributions in the patients suspected for macroprolactinemia. METHODS: From January to July in 2018, totally 317 patients with elevated PRL were subjected to the polyethylene glycol (PEG) precipitation assay. The patients with recovery rates of ≤60% were subjected for IgG subclass determination and autoantibody testing including thyroid peroxidase antibody (aTPO), antithyroglobulin antibody (aTG), and antinuclear antibodies (ANA). RESULTS: The higher the post‐PEG PRL recovery rates, the less typical hyperprolactinemia symptoms and the higher prevalence of autoantibodies were observed. The IgG1 and IgG3 were the predominant subclasses in the PRL‐IgG complexes according to the immunoprecipitation experiments. CONCLUSION: The patients with post‐PEG PRL recovery rates of <40% and 40%‐60% were likely to represent two distinct populations of different clinical presentations. The prevalence of autoantibodies and IgG subclasses distribution suggested their pathogenic significance in the development of macroprolactinemia. John Wiley and Sons Inc. 2020-06-29 /pmc/articles/PMC7676205/ /pubmed/32597541 http://dx.doi.org/10.1002/jcla.23456 Text en © 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals LLC. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Yu, Chao
Fan, Fei
Hu, Siqi
Meng, Lingxin
Xu, Dong
Wang, Juan
Chen, Lu
Liu, Jingrui
Dong, Ying
Lu, Yifan
Shen, Min
Zhai, Yanhong
Cao, Zheng
Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia
title Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia
title_full Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia
title_fullStr Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia
title_full_unstemmed Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia
title_short Evaluation of autoantibodies and immunoglobulin G subclasses in women with suspected macroprolactinemia
title_sort evaluation of autoantibodies and immunoglobulin g subclasses in women with suspected macroprolactinemia
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676205/
https://www.ncbi.nlm.nih.gov/pubmed/32597541
http://dx.doi.org/10.1002/jcla.23456
work_keys_str_mv AT yuchao evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT fanfei evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT husiqi evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT menglingxin evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT xudong evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT wangjuan evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT chenlu evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT liujingrui evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT dongying evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT luyifan evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT shenmin evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT zhaiyanhong evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia
AT caozheng evaluationofautoantibodiesandimmunoglobulingsubclassesinwomenwithsuspectedmacroprolactinemia